Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer

Abstract

An independent IRG-based prognostic index provides a practical approach for assessing patients' immune status and prognosis with BLCA. This index independently predicted outcomes of BLCA.